E. AKAHO. Development of Cyclic Tetrapeptide as an EGFR Tyrosine Kinase Inhibitor Assayed by ELISA Experiment and Docking Study: A Novel Approach. Challenges and Advances in Pharmaceutical Research Vol. 2, [S. l.], p. 108–121, 2022. DOI: 10.9734/bpi/capr/v2/1757A. Disponível em: https://stm.bookpi.org/CAPR-V2/article/view/6582. Acesso em: 4 jun. 2026.